Archive - August 2018
Pfizer accuses competitors of scaring patients away from biosimilars
Emergent buys Narcan maker for $735M
Affimed rockets on $5bn-plus Roche immuno-oncology deal
Daily Brief: Jazz Pharma and Ultragenyx approvals, Autonomous AI in retinopathy
Brexit medicine stockpiling could cost £2bn
Novartis wins key adjuvant Taf/Mek approval in Europe
EU OKs first treatment for ultra rare lysosomal storage disorder
Jazz’ Vyxeos wins EU nod for certain acute myeloid leukaemias